Updated on 2024/10/02

写真a

 
Takeshi Miyata
 
Organization
Research Field in Agriculture, Agriculture, Fisheries and Veterinary Medicine Area Faculty of Agriculture Department of Agriculture Associate Professor
Title
Associate Professor

Degree

  • Ph. D. ( 2005.9   Fukuoka University )

Research Interests

  • 感染防御

  • 遺伝子工学

  • タンパク質工学

  • 分子デザイン

  • parasite

  • molecular desgin

  • vaccine

  • malaria

  • subunit

  • Veterinary vaccine

  • silkworm

Research Areas

  • Others / Others  / タンパク質工学

  • Others / Others  / 分子デザイン

  • Life Science / Veterinary medical science  / vaccinology for domestic animal

  • Life Science / Parasitology  / vaccine depelopment against infectious diseases

Education

  • 九州大学大学院   生物資源環境科学研究科   遺伝子資源工学専攻

    2000.3

  • Fukuoka University

    2005.9

  • Yamaguchi University   Faculty of Agriculture

    1998.3

Research History

  • Kagoshima University   Faculty of Agriculture   Associate Professor

    2015.4

  • Kagoshima University   Associate Professor

    2013.4

Professional Memberships

  • 日本農芸化学会

    2021

  • 日本生物工学会

    2019

  • 日本寄生虫学会

    2015.10

  • 日本ワクチン学会

    2015.10

  • 日本生体防御学会

    2015.10

  • 日本乳酸菌学会

    2015.10

  • THE JAPANESE SOCIETY OF PARASITOLOGY

  • JAPAN SOCIETY FOR LACTIC ACID BACTERIA

  • THE JAPANESE SOCIETY FOR VACCINOLOGY

  • 日本ラクトフェリン学会

▼display all

 

Papers

  • Momoka Obayashi, Momoko Kimura, Asako Haraguchi, Mari Gotanda, Taiki Kitagawa, Misato Matsuno, Kozue Sakao, Daisuke Hamanaka, Kodai Kusakisako, Tomoshi Kameda, Hisham R Ibrahim, Hiromi Ikadai, Takeshi Miyata .  Bovine lactoferrin inhibits Plasmodium berghei growth by binding to heme. .  Scientific reports14 ( 1 ) 20344 - 20344   2024.9Bovine lactoferrin inhibits Plasmodium berghei growth by binding to heme.Reviewed International journal

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    Bovine lactoferrin (bLF) is a 77 kDa glycoprotein that is abundant in bovine breast milk and exerts various bioactive functions, including antibacterial and antiviral functions. Few studies have explored bLF activity against parasites. We found that bLF affects hemozoin synthesis by binding to heme, inhibiting heme iron polymerization necessary for Plasmodium berghei ANKA survival in infected erythrocytes, and also binds to hemozoin, causing it to disassemble. In a challenge test, bLF administration inhibited the growth of murine malaria parasites compared to untreated group growth. To determine whether the iron content of bLF affects the inhibition of malaria growth, we tested bLFs containing different amounts of iron (apo-bLF, native-bLF, and holo-bLF), but found no significant difference in their effects. This indicated that the active sites were located within the bLFs themselves. Further studies showed that the C-lobe domain of bLF can inhibit hemozoin formation and the growth of P. berghei ANKA. Evaluation of pepsin degradation products of the C-lobe identified a 47-amino-acid section, C-1, as the smallest effective region that could inhibit hemozoin formation. This study highlights bLF's potential as a novel therapeutic agent against malaria, underscoring the importance of its non-iron-dependent bioactive sites in combating parasite growth.

    DOI: 10.1038/s41598-024-70840-6

    PubMed

  • Akitsu Masuda, Jae Man Lee, Takeshi Miyata, Shintaro Sato, Atsushi Masuda, Masahiro Taniguchi, Ryosuke Fujita, Hiroshi Ushijima, Keisuke Morimoto, Takeru Ebihara, Masato Hino, Kohei Kakino, Hiroaki Mon, Takahiro Kusakabe .  High yield production of norovirus GII.4 virus-like particles using silkworm pupae and evaluation of their protective immunogenicity. .  Vaccine41 ( 3 ) 766 - 777   2023.1High yield production of norovirus GII.4 virus-like particles using silkworm pupae and evaluation of their protective immunogenicity.Reviewed International journal

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Noroviruses (NoVs) are one of the major causes of acute viral gastroenteritis in humans. Virus-like particles (VLPs) without genomes that mimic the capsid structure of viruses are promising vaccine candidates for the prevention of NoVs infection. To produce large amounts of recombinant protein, including VLPs, the silkworm-expression vector system (silkworm-BEVS) is an efficient and powerful tool. In this study, we constructed a recombinant baculovirus that expresses VP1 protein, the major structural protein of NoV GII.4. Expression analysis showed that the baculovirus-infected silkworm pupae expressed NoV VP1 protein more efficiently than silkworm larval fat bodies. We obtained about 4.9 mg of purified NoV VP1 protein from only five silkworm pupae. The purified VP1 protein was confirmed by dynamic light scattering and electron microscopy to form VLPs of approximately 40 nm in diameter. Antisera from mice immunized with the antigen blocked NoV VLPs binding to histo-blood group antigens of pig gastric mucin and also blocked NoV infection in intestinal epithelial cells derived from human induced pluripotent stem (iPS) cells. Our findings demonstrated that NoV VLP eliciting protective antibodies could be obtained in milligram quantities from a few silkworm pupae using the silkworm-BEVS.

    DOI: 10.1016/j.vaccine.2022.12.015

    PubMed

  • Takeshi Miyata, Kosuke Minamihata, Koichi Kurihara, Yui Kamizuru, Mari Gotanda, Momoka Obayashi, Taiki Kitagawa, Keita Sato, Momoko Kimura, Kosuke Oyama, Yuta Ikeda, Yukihiro Tamaki, Jae Man Lee, Kozue Sakao, Daisuke Hamanaka, Takahiro Kusakabe, Mayumi Tachibana, Hisham R Ibrahim .  Highly efficient protein expression of Plasmodium vivax surface antigen, Pvs25, by silkworm and its biochemical analysis. .  Protein expression and purification195-196   106096 - 106096   2022.8Highly efficient protein expression of Plasmodium vivax surface antigen, Pvs25, by silkworm and its biochemical analysis.Reviewed International journal

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Plasmodium vivax ookinete surface protein, Pvs25, is a candidate for a transmission-blocking vaccine (TBV) for malaria. Pvs25 has four EGF-like domains containing 22 cysteine residues forming 11 intramolecular disulfide bonds, a structural feature that makes its recombinant protein expression difficult. In this study, we report the high expression of recombinant Pvs25 as a soluble form in silkworm, Bombyx mori. The Pvs25 protein was purified from hemolymphs of larvae and pupae by affinity chromatography. In the Pvs25 expressed by silkworm, no isoforms with inappropriate disulfide bonds were found, requiring no further purification step, which is necessary in the case of Pichia pastoris-based expression systems. The Pvs25 from silkworm was confirmed to be molecularly uniform by sodium dodecyl sulfate gel electrophoresis and size-exclusion chromatography. To examine the immunogenicity, the Pvs25 from B. mori was administered to BALB/c mice subcutaneously with oil adjuvant. The Pvs25 produced by silkworm induced potent and robust immune responses, and the induced antisera correctly recognized P. vivax ookinetes in vitro, demonstrating the potency of Pvs25 from silkworm as a candidate for a malaria TBV. To the best of our knowledge, this is the first study to construct a system for mass-producing malaria TBV antigens using silkworm.

    DOI: 10.1016/j.pep.2022.106096

    PubMed

  • Akitsu Masuda, Jae Man Lee, Takeshi Miyata, Takeru Ebihara, Kohei Kakino, Masato Hino, Ryosuke Fujita, Hiroaki Mon, Takahiro Kusakabe .  Stable trimer formation of spike protein from porcine epidemic diarrhea virus improves the efficiency of secretory production in silkworms and induces neutralizing antibodies in mice. .  Veterinary research52 ( 1 ) 102 - 102   2021.7Stable trimer formation of spike protein from porcine epidemic diarrhea virus improves the efficiency of secretory production in silkworms and induces neutralizing antibodies in mice.Reviewed International journal

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Porcine epidemic diarrhea virus (PEDV) is a highly infectious pathogen of watery diarrhea that causes serious economic loss to the swine industry worldwide. Especially because of the high mortality rate in neonatal piglets, a vaccine with less production cost and high protective effect against PEDV is desired. The intrinsically assembled homotrimer of spike (S) protein on the PEDV viral membrane contributing to the host cell entry is a target of vaccine development. In this study, we designed trimerized PEDV S protein for efficient production in the silkworm-baculovirus expression vector system (silkworm-BEVS) and evaluated its immunogenicity in the mouse. The genetic fusion of the trimeric motif improved the expression of S protein in silkworm-BEVS. A small-scale screening of silkworm strains to further improve the S protein productivity finally achieved the yield of about 2 mg from the 10 mL larval serum. Mouse immunization study demonstrated that the trimerized S protein could elicit strong humoral immunity, including the S protein-specific IgG in the serum. These sera contained neutralizing antibodies that can protect Vero cells from PEDV infection. These results demonstrated that silkworm-BEVS provides a platform for the production of trimeric S proteins, which are promising subunit vaccines against coronaviruses such as PEDV.

    DOI: 10.1186/s13567-021-00971-5

    PubMed

  • Kozue Sakao, Cho Sho, Takeshi Miyata, Kensaku Takara, Rio Oda, De-Xing Hou .  Verification of In Vitro Anticancer Activity and Bioactive Compounds in Cordyceps Militaris-Infused Sweet Potato Shochu Spirits. .  Molecules (Basel, Switzerland)29 ( 9 )   2024.5Verification of In Vitro Anticancer Activity and Bioactive Compounds in Cordyceps Militaris-Infused Sweet Potato Shochu Spirits.International journal

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Many liqueurs, including spirits infused with botanicals, are crafted not only for their taste and flavor but also for potential medicinal benefits. However, the scientific evidence supporting their medicinal effects remains limited. This study aims to verify in vitro anticancer activity and bioactive compounds in shochu spirits infused with Cordyceps militaris, a Chinese medicine. The results revealed that a bioactive fraction was eluted from the spirit extract with 40% ethanol. The infusion time impacted the inhibitory effect of the spirit extract on the proliferation of colon cancer-derived cell line HCT-116 cells, and a 21-day infusion showed the strongest inhibitory effect. Furthermore, the spirit extract was separated into four fractions, A-D, by high-performance liquid chromatography (HPLC), and Fractions B, C, and D, but not A, exerted the effects of proliferation inhibition and apoptotic induction of HCT-116 cells and HL-60 cells. Furthermore, Fractions B, C, and D were, respectively, identified as adenosine, cordycepin, and N6-(2-hydroxyethyl)-adenosine (HEA) by comprehensive chemical analyses, including proton nuclear magnetic resonance (1H-NMR), Fourier transform infrared spectroscopy (FT-IR), and electrospray ionization mass spectrometry (ESI-MS). To better understand the bioactivity mechanisms of cordycepin and HEA, the agonist and antagonist tests of the A3 adenosine receptor (A3AR) were performed. Cell viability was suppressed by cordycepin, and HEA was restored by the A3AR antagonist MR1523, suggesting that cordycepin and HEA possibly acted as agonists to activate A3ARs to inhibit cell proliferation. Molecular docking simulations revealed that both adenosine and cordycepin bound to the same pocket site of A3ARs, while HEA exhibited a different binding pattern, supporting a possible explanation for the difference in their bioactivity. Taken together, the present study demonstrated that cordycepin and HEA were major bioactive ingredients in Cordyceps militaries-infused sweet potato shochu spirits, which contributed to the in vitro anticancer activity.

    DOI: 10.3390/molecules29092119

    PubMed

  • Tsukasa Orita, Satoshi Chogahara, Mayuko Okuda, Kozue Sakao, Takeshi Miyata, De-Xing Hou .  Extraction Efficiency and Alpha-Glucosidase Inhibitory Activities of Green Tea Catechins by Different Infusion Methods. .  Foods (Basel, Switzerland)12 ( 13 )   2023.7Extraction Efficiency and Alpha-Glucosidase Inhibitory Activities of Green Tea Catechins by Different Infusion Methods.International journal

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Alpha-glucosidase is an important target for glycemic control with the aim of reducing the risk of type 2 diabetes (T2D). Green tea catechins have been reported to inhibit alpha-glucosidase activity as a potential beverage to control blood glucose levels. However, the effects of the daily infusion style of green tea on tea catechins and their activity remain unclear. In this study, the extraction efficiency of catechins was investigated for 12 green tea extracts (GTEs) infused with 70% ethanol (70% EtOH for 24 h, a favored solvent for catechin extraction), room temperature water infusion (RT H2O for 24 h, an easy way to drink tea), and hot water infusion (Hot H2O for 90 s, a standard way to drink tea). Eight catechins were quantified by HPLC, and the inhibitory effect of GTEs and their catechins on alpha-glucosidase was measured with both rat intestinal enzymes and human Caco-2 cells. The inhibitory mechanism was further analyzed in silico by docking catechins to human alpha-glucosidase using Molecular Operating Environment software. The results showed that total catechins and gallate catechins were efficiently extracted in the order of 70% EtOH, RT H2O, and Hot H2O, and the inhibitory activity against alpha-glucosidase also followed a similar order. Pearson correlation analysis indicated that the alpha-glucosidase inhibitory activity of GTEs was significantly positively correlated with the contents of total catechins, especially gallate catechins. Gallate catechins, such as EGCg and ECg, showed lower IC50 values than free catechins for the enzyme in both rats and humans. In silico simulation revealed that gallate catechins were bound to the different sites with free catechins, and the docking energy of gallate catechins was lower than that of free catechins. Taken together, our data indicated that the daily infusion style of green tea significantly impacted the extraction efficiency and alpha-glucosidase inhibitory activities of catechins, which will give us insight into the use of green tea catechins for glycemic control through efficient infusion.

    DOI: 10.3390/foods12132611

    PubMed

  • Hisham Radwan Ibrahim, Ai Hitotsumatsu, Takeshi Miyata .  Identification of potent antioxidant bioactive peptides from the soluble proteins of chicken egg yolk .  Functional Food Science3 ( 6 ) 63 - 63   2023.6Reviewed

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Functional Food Center  

    Background: Eggs are an excellent  nutrient-dense food containing proteins, fats, carbohydrates, minerals, and vitamins. While many proteins are present in egg yolk, there arefew studies on their health benefits. Objective: The aim of this study was to explore the antioxidant peptides derived from the soluble protein fractions of egg yolk. Lipids and lipoproteins were removed with activated carbon and centrifugation after water dilution at acidic pH. Materials and Methods: Compared with 3.6 grams of protein in egg white, egg yolk contains 2.7 grams of protein in  a single large egg. The egg yolk soluble protein (EYsP) was digested with pepsin for 2h at pH 3.0 (P-EYsP), followed by digestion with trypsin (P-EYsP-T), α-chymotrypsin (P-EYsP-α), or both enzymes (P-EYsP-T/α). The most active digest was fractionated using sephacryl S-100 gel filtration, followed by reversed phase-HPLC of the most active fraction. The antioxidant activities were evaluated using a superoxide anion-generating system of xanthine oxidase, DPPH-scavenging assay, and yeast cells as an oxidative-stress tolerance cellular model. Results: The intact proteins (EYsP) showed antioxidant activity, but pepsin hydrolysate (P-EYsP) exhibited greater superoxide-scavenging activities than EYsP, while P-EYsP-T, P-EYsP-α and P-EYsP-T/α lacked activities. The P-EYsP and its subsequent proteases (P-EYsP-T, P-EYsP-α and P-EYsP-T/α) exhibited significant DPPH reduction, but P-EYsP-T, P-EYsP-α and P-EYsP-T/α exhibited the strongest DPPH reduction activities. MALDI-TOF-MS analysis revealed five major antioxidant peptides, two derived from yolk glycoprotein 40 (859 Da, 883Da), two from lipovitelline (901Da, 945 Da), and one from livetin (1089 Da). The peptides exhibited potent superoxide anion as well as DPPH scavenging activities and markedly enhanced the tolerance of yeast cells against peroxide-induced oxidative stress.Conclusion: The results show that these bioactive peptides hold a fascinating opportunity for their potential as nutraceuticals in prevention and combating oxidative stress-associated diseases.Keywords: Egg yolk proteins; bioactive peptides; antioxidant; superoxide-scavenging; DPPH-reduction; yeast tolerance

    DOI: 10.31989/ffs.v3i6.1110

    Other Link: https://www.ffhdj.com/index.php/FunctionalFoodScience/article/viewFile/1110/1851

  • Keisuke Tanaka, Kosuke Minamihata, Rie Wakabayashi, Jae Man Lee, Takeshi Miyata, Takahiro Kusakabe, Noriho Kamiya, Masahiro Goto .  Transdermal Transmission Blocking Vaccine for Malaria using a Solid-in-Oil Dispersion .  Journal of Pharmaceutical Sciences112 ( 2 ) 411 - 415   2022.11Transdermal Transmission Blocking Vaccine for Malaria using a Solid-in-Oil DispersionReviewed

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Malaria is a mosquito-borne infectious disease that is widespread in developing countries. Malaria vaccines are important in efforts to eradicate malaria; however, vaccines are usually administered by injection, which requires medical personnel and has a risk of causing infection. Transdermal vaccines can be administered without damaging the skin and thus are ideal for the prevention of malaria. However, the stratum corneum forms a "brick and mortar" like structure in which stratum corneum cells are embedded in a hydrophobic matrix composed of lipids, which strongly inhibits the permeation of hydrophilic substances. In the present study, we designed a transdermal vaccine against vivax malaria using a solid-in-oil (S/O) dispersion. The S/O dispersion of a transmission blocking vaccine candidate, Pvs25 from Plasmodium vivax, showed higher skin penetration than that of the aqueous solution. Mice immunized with the S/O dispersion generated antibodies at similar titers as the mice immunized by injection, over the mid- to long-term. These results provide information for the development of transdermally administered malaria vaccines toward the eradication of malaria.

    DOI: 10.1016/j.xphs.2022.10.031

    Scopus

    PubMed

  • Hisham R. Ibrahim, Ahmed S. Ahmed, Airi Komeda, Takeshi Miyata .  Lactophorin in Camel Milk Undergoing Specific Proteolysis and Exhibiting Potent Anticancer Action against Human Colon and Breast Cancer Cells Through ROS Generation .  Avicenna Journal of Medical Biochemistry10 ( 1 ) 1 - 12   2022.6Reviewed

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Maad Rayan Publishing Company  

    Background: Camel milk has been recognized for its health benefits since ancient times and has recently been attracting increasing attention as a form of medical treatment for diverse human diseases. Studies on the health benefits of camel milk attributed its medicinal effects to nutritional status, but the molecular mechanisms of proteins involved in such effects remain unknown. Objectives: The aim of this study was to explore the anticancer properties of camel milk proteins (CMPs). Methods: CMPs were fractionated into camel casein proteins (CCPs) and camel whey proteins (CWPs). The CWP exhibited the most potent anticancer activity against colon (HCT-116) and breast (MCF-7) cancer cells. The CWP was further fractionated into cationic and anionic proteins using HiTrap cationic (SP-XL) and anionic (QFF) exchange columns. Results: QFF-bound proteins (QFF-B) exhibited the strongest anticancer activities against both cancer cells. QFF-B proteins produced three peaks (P1~P3) on RP-HPLC, whereas P3 showed superior anticancer activity. The cytotoxic effects of CWP and QFF-B proteins are associated with increased production of intracellular ROS and subsequent apoptosis in both cancer cells. MALDI-TOF-MS identified lactophorin, glycation-dependent cell adhesion molecule1 (GlyCAM-1), and its three driven fragments as dominant peptides in QFF-B, while RP-HPLC-P3 contained two of them with molecular masses of 8080.3 and 9395.6 Da. The two peptides, both derived from the C-terminal of lactophorin, were the most representative peptides in the most active protein fractions (QFF-B and RP-HPLC-P3). Conclusion: The results highlight for the first time that lactophorin is the major anti-cancer ingredient in camel milk and its unique C-terminal peptides present potential candidacy as anticancer agents in nutraceutical and pharmacological applications.

    DOI: 10.34172/ajmb.2022.01

  • Masayuki Nakamura, Naoaki Tsuda, Takeshi Miyata, Makoto Ikenaga .  Antimicrobial effect and mechanism of bovine lactoferrin against the potato common scab pathogen Streptomyces scabiei. .  PloS one17 ( 2 ) e0264094   2022Antimicrobial effect and mechanism of bovine lactoferrin against the potato common scab pathogen Streptomyces scabiei.Reviewed International journal

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Lactoferrin (LF) is a multifunctional protein with a broad spectrum of antimicrobial activities. In this study, we investigated the antimicrobial activity of LF against the potato common scab pathogen Streptomyces scabiei, which causes severe damage to potato tubers. LF derived from bovine (bLF) had much higher activity against S. scabiei than human LF. The minimal inhibitory concentration of bLF was 3.9 μM. The effects of both apo-bLF (iron-free) and holo-bLF (iron-saturated) on S. scabiei were not different. Bovine lactoferricin (LFcinB), a short peptide with a length of 25 amino acid residues located in the N-terminal region of bLF, showed antimicrobial activity against S. scabiei, similar to that of bLF. These results indicated that the antimicrobial activity of bLF against S. scabiei cannot be attributed to its iron-chelating effect but to the bioactivity of its peptides. When S. scabiei was treated with the fusion protein of mCherry-LFcinB (red fluorescent protein) expressed in Escherichia coli, the pseudohyphal cells instantly glowed, indicating that the peptide electrostatically binds to the surface of S. scabiei. An assay of synthetic peptides, with modified number of arginine (Arg) and tryptophan (Trp) residues based on the antimicrobial center (RRWQWR) of LFcinB showed that Trp residues are implicated in the antimicrobial activity against S. scabiei; however, Arg residues are also necessary to carry Trp residues to the cell surface to fully exert its activity. Although the single amino acid effect of Trp had low activity, Trp derivatives showed much higher activity against S. scabiei, suggesting that the derivatives effectively bind to the cell surface (cell membrane) by themselves without a carrier. Thus, amino acid derivatives might be considered effective and alternative antimicrobial substances.

    DOI: 10.1371/journal.pone.0264094

    PubMed

  • Kodai Kusakisako, Takeshi Miyata, Kozo Fujisaki, Tetsuya Tanaka .  Host Immunization with Recombinant Tick Antigen and Evaluation of Host Immune Response. .  Methods in molecular biology (Clifton, N.J.)2411   331 - 341   2022Host Immunization with Recombinant Tick Antigen and Evaluation of Host Immune Response.International journal

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Ticks are classified as hematophagous arthropods and transfer a variety of pathogens-such as viruses, bacteria, and protozoans-to vertebrate hosts during blood feeding. These transmitted pathogens cause infectious diseases that continue to affect both humans and animals worldwide. Chemical acaricides are commonly used for tick control to prevent infectious diseases. However, the continuous use of acaricides leads to the emergence of acaricide-resistant tick species; thus, alternative methods for tick control are necessary. Vaccination of vertebrate hosts with tick-derived molecules is considered to be a better alternative against ticks than chemical acaricides because ticks feed on host blood for several days and also concentrate the host blood with antibodies. On the other hand, the host's immune responses against pathogens mainly take two pathways-Th1 (cell-mediated immunity) and Th2 (humoral immunity) pathways. Thus, the vaccine can suggest which immune pathway is more important for vaccination. This chapter describes the procedures of immunizing laboratory animals-mice-with a recombinant tick protein for the preliminary evaluation of its potential as an anti-tick vaccine candidate. In addition, the method of evaluating the antigen-specific antibody production in the host using ELISA is described, as is the subsequent tick-infestation challenge for determining the effectiveness of vaccination.

    DOI: 10.1007/978-1-0716-1888-2_19

    PubMed

  • Shin Irumagawa, Kaito Kobayashi, Yutaka Saito, Takeshi Miyata, Mitsuo Umetsu, Tomoshi Kameda, Ryoichi Arai .  Rational thermostabilisation of four-helix bundle dimeric de novo proteins. .  Scientific reports11 ( 1 ) 7526 - 7526   2021.4Rational thermostabilisation of four-helix bundle dimeric de novo proteins.Reviewed International journal

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The stability of proteins is an important factor for industrial and medical applications. Improving protein stability is one of the main subjects in protein engineering. In a previous study, we improved the stability of a four-helix bundle dimeric de novo protein (WA20) by five mutations. The stabilised mutant (H26L/G28S/N34L/V71L/E78L, SUWA) showed an extremely high denaturation midpoint temperature (Tm). Although SUWA is a remarkably hyperstable protein, in protein design and engineering, it is an attractive challenge to rationally explore more stable mutants. In this study, we predicted stabilising mutations of WA20 by in silico saturation mutagenesis and molecular dynamics simulation, and experimentally confirmed three stabilising mutations of WA20 (N22A, N22E, and H86K). The stability of a double mutant (N22A/H86K, rationally optimised WA20, ROWA) was greatly improved compared with WA20 (ΔTm = 10.6 °C). The model structures suggested that N22A enhances the stability of the α-helices and N22E and H86K contribute to salt-bridge formation for protein stabilisation. These mutations were also added to SUWA and improved its Tm. Remarkably, the most stable mutant of SUWA (N22E/H86K, rationally optimised SUWA, ROSA) showed the highest Tm (129.0 °C). These new thermostable mutants will be useful as a component of protein nanobuilding blocks to construct supramolecular protein complexes.

    DOI: 10.1038/s41598-021-86952-2

    PubMed

  • Akitsu Masuda, Jae Man Lee, Takeshi Miyata, Hiroaki Mon, Keita Sato, Kosuke Oyama, Yasuteru Sakurai, Jiro Yasuda, Daisuke Takahashi, Tadashi Ueda, Yuri Kato, Motohiro Nishida, Noriko Karasaki, Kohei Kakino, Takeru Ebihara, Takumi Nagasato, Masato Hino, Ayaka Nakashima, Kengo Suzuki, Yoshino Tonooka, Miyu Tanaka, Takato Moriyama, Hirokazu Nakatake, Ryosuke Fujita, Takahiro Kusakabe .  Optimization of SARS-CoV-2 Spike Protein Expression in the Silkworm and Induction of Efficient Protective Immunity by Inoculation With Alum Adjuvants. .  Frontiers in immunology12   803647 - 803647   2021Optimization of SARS-CoV-2 Spike Protein Expression in the Silkworm and Induction of Efficient Protective Immunity by Inoculation With Alum Adjuvants.Reviewed International journal

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The newly emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing a spread of coronavirus disease 2019 (COVID-19) globally. In order to end the COVID-19 pandemic, an effective vaccine against SARS-CoV-2 must be produced at low cost and disseminated worldwide. The spike (S) protein of coronaviruses plays a pivotal role in the infection to host cells. Therefore, targeting the S protein is one of the most rational approaches in developing vaccines and therapeutic agents. In this study, we optimized the expression of secreted trimerized S protein of SARS-CoV-2 using a silkworm-baculovirus expression vector system and evaluated its immunogenicity in mice. The results showed that the S protein forming the trimeric structure was the most stable when the chicken cartilage matrix protein was used as the trimeric motif and could be purified in large amounts from the serum of silkworm larvae. The purified S protein efficiently induced antigen-specific antibodies in mouse serum without adjuvant, but its ability to induce neutralizing antibodies was low. After examining several adjuvants, the use of Alum adjuvant was the most effective in inducing strong neutralizing antibody induction. We also examined the adjuvant effect of paramylon from Euglena gracilis when administered with the S protein. Our results highlight the effectiveness and suitable construct design of the S protein produced in silkworms for the subunit vaccine development against SARS-CoV-2.

    DOI: 10.3389/fimmu.2021.803647

    PubMed

  • Hisham R Ibrahim, Hiroki Isono, Takeshi Miyata .  Potential antioxidant bioactive peptides from camel milk proteins. .  Animal nutrition (Zhongguo xu mu shou yi xue hui)4 ( 3 ) 273 - 280   2018.9Potential antioxidant bioactive peptides from camel milk proteins.Reviewed

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Camel milk is traditionally considered to have medicinal characteristics that it has potential health benefits and could help to treat several illnesses. Particularly, it is closest to human breast milk and has high levels of nutrients and bioactive components. The aim of this study was to explore the antioxidant peptides derived from protein fractions of camel milk. Camel milk proteins (CMP) were fractionated into camel casein protein (CCP) and camel whey protein (CWP), which were hydrolyzed with pepsin to produce peptic digests P-CCP and P-CWP, respectively. RP-HPLC was used for fractionation of the peptides from the P-CCP and P-CWP. The antioxidant activities were evaluated using superoxide anion generating system of xanthine oxidase (XOD) and 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging assay. Active peptides were analyzed using matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF-MS) whereas a number of antioxidant peptides, with masses ranging from 913 to 2,951 Da, derived mainly from alpha-casein, lactophorin and lactoferrin, were identified. When yeast cells are used as a system for modeling mitochondrial disease, the peptides in caseins and whey fractions significantly enhanced the tolerance of yeast cells against peroxide-induced oxidative stress. The results show that both caseins and whey proteins of camel milk possess bioactive peptides with significant radical-scavenging activities and thus herald a fascinating opportunity for their potential as nutraceuticals or therapeutic peptides for prevention and treatment of oxidative stress-associated diseases.

    DOI: 10.1016/j.aninu.2018.05.004

    PubMed

    Other Link: https://www.ncbi.nlm.nih.gov/pubmed/30175255

  • Akitsu Masuda, Jae Man Lee, Takeshi Miyata, Tetsuo Sato, Shizuka Hayashi, Masato Hino, Daisuke Morokuma, Noriko Karasaki, Hiroaki Mon, Takahiro Kusakabe .  Purification and characterization of immunogenic recombinant virus-like particles of porcine circovirus type 2 expressed in silkworm pupae. .  The Journal of general virology99 ( 7 ) 917 - 926   2018.7Purification and characterization of immunogenic recombinant virus-like particles of porcine circovirus type 2 expressed in silkworm pupae.

     More details

    Porcine circovirus type 2 (PCV2) is a primary causative agent of postweaningmultisystemic wasting syndrome (PMWS), which has a significant economic impact on the swine industry. The capsid protein (Cap) encoded by ORF2 of the viral genome has been used effectively as a vaccine against PCV2 infection. The Cap protein can spontaneously assemble into virus-like particles (VLPs) that are safe and highly immunogenic for vaccine applications. Several expression systems, including bacteria, yeast and insect cells, have been utilized to produce PCV2 VLPs. However, in some cases, the recombinant Cap (rCap) proteins produced in bacteria and yeast do not assemble spontaneously. In this study, we expressed rCap protein using a silkworm-baculovirus expression vector system (silkworm-BEVS) for mass production of PCV2 VLPs and established a simple three-step protocol for its purification from pupae: extraction by detergent, ammonium sulfate precipitation and anion exchange column chromatography. Size-exclusion chromatography (SEC) analysis and transmission electron microscope (TEM) observation showed that purified rCap proteins formed VLPs with a similar morphology to that of the original virus. Furthermore, the VLPs produced in silkworms were capable of inducing neutralizing antibodies against PCV2 in mice. Our results demonstrated that the silkworm system is a powerful tool for the production of PCV2 VLPs and will be useful for the development of a reliable and cost-effective PCV2 vaccine.

    DOI: 10.1099/jgv.0.001087

    PubMed

  • Kodai Kusakisako, Takeshi Miyata, Masashi Tsujio, Remil Linggatong Galay, Melbourne Rio Talactac, Emmanuel Pacia Hernandez, Kozo Fujisaki, Tetsuya Tanaka .  Evaluation of vaccine potential of 2-Cys peroxiredoxin from the hard tick Haemaphysalis longicornis. .  Experimental & applied acarology74 ( 1 ) 73 - 84   2018.1Evaluation of vaccine potential of 2-Cys peroxiredoxin from the hard tick Haemaphysalis longicornis.

     More details

    Ticks require blood feeding on vertebrate animals throughout their life cycle, and also concentrate the iron-containing blood, resulting in a high concentration of hydrogen peroxide (H2O2). High concentrations of H2O2 are harmful to organisms, due to their serious damage of macromolecules. Ticks have antioxidant enzymes, such as peroxiredoxins (Prxs), that scavenge H2O2. Prxs may have important roles in regulating the H2O2 concentration in ticks during blood feeding and oviposition. Moreover, Prxs are considered potential vaccine candidates in other parasites, such as Leishmania and Fasciola. In the present study, the efficacy of a tick Prx (HlPrx2) as a vaccine candidate antigen was evaluated. First, recombinant HlPrx2 (rHlPrx2) was expressed in Escherichia coli, and then, its purity and endotoxin levels were confirmed prior to administration. The rHlPrx2 proteins were of high purity with acceptably low endotoxin levels. Second, the ability of rHlPrx2 administration to stimulate mouse immunity was evaluated. The rHlPrx2 protein, with or without an adjuvant, could stimulate immunity in mice, especially the IgG1 of Th2 immune response. Using Western blot analysis, we also observed whether rHlPrx2-immunized mice sera could recognize native HlPrx2 protein in crude tick midgut proteins. Western blot analysis demonstrated that rHlPrx2-administrated mouse sera could detect the native HlPrx2. Finally, the effects of rHlPrx2 immunization in mice were studied using nymphal ticks. Although the challenged ticks were not affected by rHlPrx2 immunization, rHlPrx2 still might be considered as a vaccine candidate against ticks because of its high immunogenicity.

    DOI: 10.1007/s10493-018-0209-3

    PubMed

  • Hisham R Ibrahim, Kosuke Hamasaki, Takeshi Miyata .  Novel peptide motifs from lysozyme suppress pro-inflammatory cytokines in macrophages by antagonizing toll-like receptor and LPS-scavenging action. .  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences107   240 - 248   2017.9Novel peptide motifs from lysozyme suppress pro-inflammatory cytokines in macrophages by antagonizing toll-like receptor and LPS-scavenging action.

     More details

    Publisher:ELSEVIER SCIENCE BV  

    Lysozyme is commonly found in spots where bacterial infections are most likely to enter the body. Earlier we found that lysozyme possesses five antimicrobial peptide motifs in its N-terminal region which can be generated by newborn pepsin. In this study, we explore the role of these peptides in the anti-inflammatory activity of lysozyme. The five peptides, helix1 (H1), helix2 (H2), H1 and H2 connected with a loop (HLH), H2 extended with either 2 β-strands (H2-S12) or 3 β-strands (H2-S13), were synthesized and examined for anti-inflammatory action. The five peptides dose-dependently decreased, to different degrees, expression of pro-inflammatory cytokines, TNF-α, IL-6 and IL-1β, in lipopolysaccharide (LPS)- or interferon-gamma (INF-γ)-stimulated mouse macrophage cells (RAW264.7). The HLH peptide and its individual helices (H1 and H2) were markedly the most potent anti-inflammatory. When macrophage cells were stimulated with live bacteria (E. coli), H1 peptide was the most powerful suppressor of TNF-α and IL-6 expression, providing evidence that the peptide is able to antagonize the pathogen-induced inflammatory response. Receptor binding assay and docking simulation provided evidence that H1 peptide bind specifically to the pocket for endotoxin binding of the toll-like receptor 4 (TLR-4) of macrophage. The results demonstrate, for the first time, the molecular basis of anti-inflammatory action of lysozyme that N-terminal helical peptides are the main contributors. This exciting finding offers new classes of therapeutic peptides with potential in the treatment of infection-induced inflammatory diseases.

    DOI: 10.1016/j.ejps.2017.07.005

    Web of Science

    PubMed

  • Hisham R. Ibrahim, Ahmed S. Ahmed, Takeshi Miyata .  Novel angiotensin-converting enzyme inhibitory peptides from caseins and whey proteins of goat milk .  JOURNAL OF ADVANCED RESEARCH8 ( 1 ) 63 - 71   2017.1Novel angiotensin-converting enzyme inhibitory peptides from caseins and whey proteins of goat milk

     More details

    Publisher:ELSEVIER SCIENCE BV  

    Angiotensin-converting enzyme (ACE) plays a central role in blood pressure regulation by producing the vasoconstrictor angiotensin II. The inhibition of ACE with natural inhibitors, as alternatives to avoid the side effect of synthetic drugs, is a major target in the prevention of hypertension. In this study, we examined the separated caseins and whey proteins of goat milk for the presence of ACE inhibitory peptides. Digestion of isolated whey proteins and caseins of goat milk by gastric pepsin generated soluble hydrolysates exhibiting significant inhibition of ACE compared to weak inhibition by undigested proteins. The hydrolysates were fractionated by size exclusion chromatography, Sephacryl S-100 column, into four fractions (F1-F4). The late-eluting fraction (F4) of either whey or caseins exhibited greater ACE inhibition. Peptides in both F4 fractions, isolated by RP-HPLC, exhibited variable ACE inhibitory activities with the hydrophobic peptide peaks being the most potent ACE inhibitors. MALDI-TOF MS/MS resulted in identification of three potent ACE inhibitory peptides: PEQSLACQCL from beta-lactoglobulin (residues 113-122), QSLVYPFTGPI from beta-casein (residues 56-66), and ARHPHPHLSFM from kappa-casein (residues 96-106). The peptides from whey and caseins exert significant ACE inhibitory activities comparable to that of captopril, an antihypertensive drug, exhibiting IC50 values of 4.45 mu M and 4.27 mu M, respectively. The results introduce, for the first time, new potent ACE-inhibitory peptides that can be released by gastric pepsin of goat milk whey and caseins and thus may pave the way for their candidacy as anti-hypertensive bioactive peptides and prevention of associated disorders. (C) 2016 Production and hosting by Elsevier B.V. on behalf of Cairo University.

    DOI: 10.1016/j.jare.2016.12.002

    Web of Science

    PubMed

  • 3. Yukihiro Tamaki, Tetsuya Harakuni, Rui Yamaguchi, Takeshi Miyata, Takeshi Arakawa .  Cholera toxin B subunit pentamer reassembled from Escherichia coli inclusion bodies for use in vaccination .  Vaccine34 ( 10 ) 1268 - 1274   2016Cholera toxin B subunit pentamer reassembled from Escherichia coli inclusion bodies for use in vaccinationReviewed

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier  

    DOI: 10.1016/j.vaccine.2016.01.034

  • Maeda H, Kurisu K, Miyata T, Kusakisako K, Galay RL, Rio TM, Mochizuki M, Fujisaki K, Tanaka T .  Identification of the Babesia-responsive leucine-rich repeat domain-containing protein from the hard tick Haemaphysalis longicornis .  Parasitol. Res   2015Identification of the Babesia-responsive leucine-rich repeat domain-containing protein from the hard tick Haemaphysalis longicornisReviewed

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  • Ibrahim HR, Tatsumoto S, Hajime O, Immerseel FV, Raspoet R, Miyata T. .  A novel antibiotic-delivery system by using ovotransferrin as targeting molecule. .  Eur. J. Pharm. Sci   2014.10A novel antibiotic-delivery system by using ovotransferrin as targeting molecule. Reviewed

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  • Galay RL, Miyata T, Umemiya-Shirafuji R, Maeda H, Kusakisako K, Mochizuki M, Fujisaki K, Tanaka T. .  Evaluation and comparison of the potential of two ferritins as anti-tick vaccine antigens against Haemaphysalis longicornis. .  Parasit. Vectors7 ( 1 ) 482   2014.10Evaluation and comparison of the potential of two ferritins as anti-tick vaccine antigens against Haemaphysalis longicornis.Reviewed

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  • Hiramatsu Y, Yamamoto M, Satho T, Irie K, Kai A, Uyeda S, Toda A, Miyata T, Miake F, Arakawa T, Kashige N .  Recombinant fusion protein of cholera toxin B subunit with YVAD secreted by Lactobacillus casei inhibits lipopolysaccharide-induced caspase-1 activation and subsequent IL-1 beta secretion in Caco-2 cells. .  BMC Biotechnology14 ( 38 )   2014.5Recombinant fusion protein of cholera toxin B subunit with YVAD secreted by Lactobacillus casei inhibits lipopolysaccharide-induced caspase-1 activation and subsequent IL-1 beta secretion in Caco-2 cells.Reviewed

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  • Arakawa T, Harakuni T, Miyata T, Tafuku S, Tadano M. .  Tricomponent fusion complex comprising a viral antigen, a pentameric α-helical coiled-coil, and an immunoglobulin-binding domain as an effective antiviral vaccine. .  Vaccine32   864 - 871   2014.2Tricomponent fusion complex comprising a viral antigen, a pentameric α-helical coiled-coil, and an immunoglobulin-binding domain as an effective antiviral vaccine.Reviewed

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

  • Arakawa T, Tsuboi T, Sattabongkot J, Sakao K, Torii M, Miyata T. .  Tricomponent complex loaded with a mosquito-stage antigen of malaria parasite induces potent transmission-blocking immunity. (2014) Clinical Vaccine and Immunology .  Clinical Vaccine and Immunology21   561 - 569   2014.2Tricomponent complex loaded with a mosquito-stage antigen of malaria parasite induces potent transmission-blocking immunity. (2014) Clinical Vaccine and ImmunologyReviewed

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  • Ibrahim HR, Hozono A, Fukami M, Shaban MA, Miyata T. .  Expression of ovotransferrin enhances tolerance of yeast cells toward oxidative stress. .  J. Agric. Food Chem.61   6358 - 6365   2013.6Expression of ovotransferrin enhances tolerance of yeast cells toward oxidative stress.Reviewed

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  • Miyata T, Tafuku S, Harakuni T, Tadano M, Yoshimoto N, Iijima M, Matsuo H, Matsuzaki G, Kuroda S, Arakawa T. .  A bio-nanocapsule containing envelope (E) protein domain III of Japanese encephalitis virus (JEV) protects mice against lethal JEV infection. .  Microbiology and Immunology 57 ( 6 ) 470 - 477   2013.6A bio-nanocapsule containing envelope (E) protein domain III of Japanese encephalitis virus (JEV) protects mice against lethal JEV infection. Reviewed

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  • Okuno T, Kashige N, Satho T, Irie K, Hiramatsu Y, Sharmin T, Fukumitsu Y, Uyeda S, Yamada S, Harakuni T, Miyata T, Arakawa T, Imoto M, Toda A, Nakashima Y, Miake F. .  Expression and secretion of cholera toxin B subunit in lactobacilli. .  Biol. Pharm. Bull.36 ( 6 ) 952 - 958   2013.6Expression and secretion of cholera toxin B subunit in lactobacilli.Reviewed

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  • Satho T, Nagano Y, Eshita Y, Hisatomi Y, Sakata A, Miyata T, Kashige N, Miake F, Runtuwen RL, Fukushi S, Saijyo M, Kurane I, Morioka S, MizutaniT. .  Inhibitory effects of JNK on Aedes albopictus early larval development .  Urban Pest Management2   7 - 13   2012.6Inhibitory effects of JNK on Aedes albopictus early larval development Reviewed

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  • Miyata T, Oshiro S, Harakuni T, Taira T, Matsuzaki G, Arakawa T. .  Physicochemically stable cholera toxin B subunit pentamer created by peripheral molecular constraints imposed by de novo-introduced intersubunit disulfide crosslinks. .  Vaccine30   4225 - 4232   2012.6Physicochemically stable cholera toxin B subunit pentamer created by peripheral molecular constraints imposed by de novo-introduced intersubunit disulfide crosslinks.Reviewed

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

▼display all

Books

  • ラクトフェリン2019(基盤的基礎研究の深化と応用開発研究の進化)

    大林桃百香、筏井宏美、宮田健( Role: Joint author)

    アイ・ケイコーポレーション  2019 

     More details

    Language:Japanese Book type:Scholarly book

  • ラクトフェリンの基盤的基礎研究の深化と応用開発研究の進化

    日本ラクトフェリン学会第, 回学術集会実行委員会, 日本ラクトフェリン学会

    アイ・ケイコーポレーション  2019  ( ISBN:9784874923672

     More details

  • スマートセルインダストリー : 微生物細胞を用いた物質生産の展望

    久原 哲

    シーエムシー出版  2018  ( ISBN:9784781313344

     More details

  • アジュバント開発研究の新展開

    石井 健, 山西 弘一

    シーエムシー出版  2017  ( ISBN:9784781312149

     More details

MISC

  • 家畜感染症のための食べるワクチンの開発研究

    南奈津, 平松健太郎, 江崎啓一, 中武洋和, 佐々木友樹, 谷口雅浩, 二神泰基, 玉置尚徳, 増田亮津, 李在萬, 日下部宜宏, 宮田健

    日本食品科学工学会西日本支部大会講演要旨   2022   2022

     More details

  • カイコ発現系による細菌性毒素を応用した粘膜ワクチン用アジュバントの構築と機能性評価

    村田亜未, 里圭太, 玉城志博, 新川武, 増田亮津, 李在萬, 日下部宜宏, 宮田健

    日本食品科学工学会西日本支部大会講演要旨   2022   2022

     More details

  • Evaluation the Protein Stability by Molecular Dynamics Simulation

    Tomoshi Kameda, Kaito Kobayashi, Shin Irumagawa, Ryoichi Arai, Yutaka Saito, Takeshi Miyata, Mitsuo Umetsu

    BIOPHYSICAL JOURNAL   118 ( 3 )   509A - 509A   2020.2

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:CELL PRESS  

    Web of Science

  • Silkworm‐BEVSを用いたPRRSVに対するVLPワクチンの作製検討

    長井亮, 李在萬, 宮田健, 増田亮津, 日下部宜宏

    日本蚕糸学会大会・蚕糸・昆虫機能学術講演会講演要旨集   89th   67   2019.3

     More details

  • アニオン性タンパク質ナノ粒子TIP60とカチオン性タンパク質の相互作用解析

    川上了史, 那須英里圭, 宮田健, 宮本憲二

    日本化学会春季年会講演予稿集(CD-ROM)   99th   ROMBUNNO.1G3‐53   2019.3

     More details

  • 昆虫工場を利用したウイルス様粒子ワクチン生産系の確立とその応用

    増田 亮津, 宮田 健, 南畑 孝介, 神谷 典穂, 李 在萬, 日下部 宜宏

    衛生動物   70 ( Suppl. )   68 - 68   2019.3

     More details

    Publisher:日本衛生動物学会  

  • ジャガイモそうか病菌に対するラクトフェリン(LF)の抗菌作用について

    津田尚明, 中村正幸, 宮田健, 岩井久

    日本植物病理学会大会プログラム・講演要旨予稿集   2018   106   2018.3

     More details

  • カイコ発現マラリアワクチン抗原の機能性について

    宮田健, LEE J M, 日下部宜宏

    日本農芸化学会大会講演要旨集(Web)   2018   ROMBUNNO.4SY12‐3 (WEB ONLY)   2018.3

     More details

  • 酵素反応を利用した分子デザインによる機能性ワクチン抗原の作製とマラリアワクチンへの応用

    栗原浩一, 李在萬, 日下部宜宏, 南畑孝介, 高原茉莉, 神谷典穂, イブラヒム ヒッシャム, 宮田健

    日本ワクチン学会学術集会プログラム・抄録集   22nd   105   2018

     More details

  • マダニペルオキシレドキシンの特性解明(―ペルオキシレドキシンの性状解析並びに吸血・産卵に果たす役割について―)

    草木迫浩大, 草木迫浩大, 正谷達謄, 宮田健, GALAY Remil, 白藤(梅宮)梨可, 前田大輝, TALACTAC Melbourne, TALACTAC Melbourne, HERNANDEZ Emmanuel, HERNANDEZ Emmanuel, 辻尚利, 望月雅美, 藤崎幸蔵, 田仲哲也, 田仲哲也

    日本獣医学会学術集会講演要旨集   160th   202   2017.8

     More details

  • マダニペルオキシレドキシンの特性解明(ペルオキシレドキシンの性状解析並びに吸血・産卵に果たす役割について)

    草木迫 浩大, 正谷 達謄, 宮田 健, Galay Remil, 白藤 梨可, 宮, 前田 大輝, Talactac Melbourne, Hernandez Emmanuel, 辻 尚利, 望月 雅美, 藤崎 幸蔵, 田仲 哲也

    日本獣医学会学術集会講演要旨集   160回   202 - 202   2017.8

     More details

    Publisher:(公社)日本獣医学会  

▼display all

Presentations

  • Mio Akutsu, Hikaru Nakazawa, Takeshi Miyata, Mitsuo Umetsu   Potential of aggregated antigens for strong immunity.   International conference

    11th Annual PEGS Europe 

     More details

    Event date: 2019.11

    Language:English   Presentation type:Oral presentation (general)  

    Venue:LISOBN, PORTGAL  

  • 北川 大樹、大林 桃百香、李 在萬、日下部 宜宏、Ibrahim Hisham、宮田健   魚類由来異物結合タンパク質のヘモゾイン形成阻害能について  

    第75回日本寄生虫学会西日本支部大会  日本寄生虫学会西日本支部

     More details

    Event date: 2019.9

    Language:English   Presentation type:Oral presentation (general)  

    Venue:金沢大学医学部  

  • 栗原 浩一、門川 淳一、李 在萬、日下部 宜宏、宮田 健   ナノ粒子多糖 (NPG) と DNA を利用した新規マラリアワクチン開発基盤技術の構築  

    第70回日本寄生虫学会南日本支部大会  第70回日本寄生虫学会南日本支部

     More details

    Event date: 2017.11

    Language:Japanese  

    Venue:奄美大島Ai広場、鹿児島  

    国内学会

  • 五反田 麻里、保延 真奈、筏井 宏実、宮田 健   ウシラクトフェリンを活用した抗マラリア薬の高機能化  

    第70回日本寄生虫学会南日本支部大会  第70回日本寄生虫学会南日本支部

     More details

    Event date: 2017.11

    Language:Japanese  

    Venue:奄美大島Ai広場、鹿児島  

    国内学会

  • 山田清太郎、原國哲也、玉城志博、宮田健、坪井敬文、Jetsumon Sattabongkot、橘真由美、鳥居本美、新川武   三日熱マラリア伝搬阻止ワクチン候補抗原(Pvs25)の反復整列化とそのワクチン効果  

    第67回日本寄生虫学会南日本支部大会・第64回日本衛生動物学会南日本支部大会  第67回日本寄生虫学会南日本支部大会・第64回日本衛生動物学会南日本支部大会

     More details

    Event date: 2014.11

    Language:Japanese  

    Venue:てんぶすホール、沖縄  

    国内学会

  • 玉城志博、原國哲也、宮田健、坪井敬文、Jetsumon Sattabongkot、橘真由美、鳥居本美、新川武   3部構成免疫賦活システム(TIPS)のマラリア伝搬阻止ワクチンへの応用  

    第67回日本寄生虫学会南日本支部大会・第64回日本衛生動物学会南日本支部大会  第67回日本寄生虫学会南日本支部大会・第64回日本衛生動物学会南日本支部大会

     More details

    Event date: 2014.11

    Language:Japanese  

    Venue:てんぶすホール、沖縄  

    国内学会

  • 原國哲也、宮田健、平良東紀、新川武   酵母発現コレラトキシンB鎖タンパク質(CTB)の糖鎖を利用した部位特異的化学融合法とそのマラリアワクチンへの応用  

    第67回日本寄生虫学会南日本支部大会・第64回日本衛生動物学会南日本支部大会  第67回日本寄生虫学会南日本支部大会・第64回日本衛生動物学会南日本支部大会

     More details

    Event date: 2014.11

    Language:Japanese  

    Venue:てんぶすホール、沖縄  

    国内学会

  • 新川武、宮田健、原國哲也、橘真由美、Jetsumon Sattabongkot、鳥居本美、坪井敬文   経鼻マラリア伝搬阻止ワクチン  

    第67回日本寄生虫学会南日本支部大会・第64回日本衛生動物学会南日本支部大会  第67回日本寄生虫学会南日本支部大会・第64回日本衛生動物学会南日本支部大会

     More details

    Event date: 2014.11

    Language:Japanese  

    Venue:てんぶすホール、沖縄  

    国内学会

  • 柿本 麻美子、小森園 亮、田仲 哲也、李 長春、渡部 久実、Ibrahim Hisham、若林 裕之、山内 恒治、宮田 健   ナノ粒子グリコーゲン(NPG)を用いた新規マラリアワクチン開発の技術基盤構築  

    第19回日本フードファクター学会  第19回日本フードファクター学会

     More details

    Event date: 2014.11

    Language:Japanese  

    Venue:鹿児島大学、鹿児島  

    国内学会

  • 小森園 亮、柿本 麻美子、田仲 哲也、李 長春、渡部 久実、Ibrahim Hisham、若林 裕之、山内 恒治、宮田 健   ラクトフェリンによる抗マラリア原虫機能の解析  

    第19回日本フードファクター学会  第19回日本フードファクター学会

     More details

    Event date: 2014.11

    Language:Japanese  

    Venue:鹿児島大学、鹿児島  

    国内学会

  • Galay Remil Linggatong、白藤(梅宮)梨可、宮田 健、草木迫 浩大、前田 大輝、望月 雅美、藤崎 幸蔵、田仲 哲也   The critical functions of ferritins in Haemaphysalis longicornis and their potential as target molecules for tick control  

    第157回日本獣医学学術集会  第157回日本獣医学学術集会

     More details

    Event date: 2014.9

    Language:Japanese  

    Venue:北海道大学、北海道  

    国内学会

  • 原國哲也、山田清太郎、宮田健、山口類、玉城志博、坪井敬文、Jetsumon Sattabongkot、橘真由美、鳥居本、新川武   三日熱マラリア伝搬阻止ワクチン候補抗原(Pvs25)の反復整列化とそのワクチン効果  

    第83回日本寄生虫学大会  第83回日本寄生虫学大会

     More details

    Event date: 2014.3

    Language:Japanese  

    Venue:愛媛大学、愛媛  

    国内学会

  • Remil Linggatong, Takeshi Miyata, Rika Umemiya-Shirafuji, Hiroki Maeda, Kodai Kusakisako, Masami Mochizuki, Kozo Fujisaki, Tetsuya Tanaka.   The potential of recombinant ferritins as anti-tick vaccine against Haemaphysalis longicornis.  

    第83回日本寄生虫学大会  第83回日本寄生虫学大会

     More details

    Event date: 2014.3

    Language:Japanese  

    Venue:愛媛大学、愛媛  

    国内学会

  • Masayuki Fukui, Masayuki Umemura, Takeshi Miyata, Tetsuya Harakuni, Takeshi Arakawa, Goro Matsuzaki.   Induction of early protective immunity against pulmonary Mycobcterium tuberculosis infection in mice by combination of BCG priming vaccine and boosting mucosal vaccine with a recombinant mycobacterial antigen.   International conference

    第42回日本免疫学会  第42回日本免疫学会

     More details

    Event date: 2013.12

    Language:English  

    Venue:幕張メッセ、千葉  

    国際学会

  • 玉城志博、宮田健、原國哲也、坪井敬文、Jetsumon Sattabongkot、橘真由美、鳥居本美、新川武   マラリアワクチン抗原搭載三部構成免疫賦活システム(TIPS)のマラリア伝搬阻止ワクチン機能解析  

    第54回日本熱帯医学会大会  第54回日本熱帯医学会大会

     More details

    Event date: 2013.10

    Language:Japanese  

    Venue:長崎ブリックホール、長崎  

    国内学会

  • 山口類、新川武、宮田健、原國哲也、田福宣治、只野昌之   日本脳炎ウイルス抗原、コイルドコイル5量体、免疫グロブリン結合ドメインから構成される三部構成複合体のワクチン機能解析  

    第54回日本熱帯医学会大会  第54回日本熱帯医学会大会

     More details

    Event date: 2013.10

    Language:Japanese  

    Venue:長崎ブリックホール、長崎  

    国内学会

  • 原國哲也、宮田健、坪井敬文、Jetsumon Sattabongkot、橘真由美、鳥居本美、新川武   コレラトキシンB鎖と三日熱マラリア伝搬阻止ワクチン抗原Pvs25の融合体構築とそのワクチン機能解析  

    第54回日本熱帯医学会大会  第54回日本熱帯医学会大会

     More details

    Event date: 2013.10

    Language:Japanese  

    Venue:長崎ブリックホール、長崎  

    国内学会

  • 原國哲也、宮田健、山田清太郎、山口類、坪井敬文、Jetsumon Sattabongkot、橘真由美、鳥居本美、新川武   Plasmodium yoelii MSP1の高分子量化による可溶性凝集体化とそのワクチン機能増強効果  

    第82回日本寄生虫学会大会  第82回日本寄生虫学会大会

     More details

    Event date: 2013.3

    Language:Japanese  

    Venue:東京  

    国内学会

  • 山田清太郎、宮田健、原國哲也、坪井敬文、Jetsumon Sattabongkot、橘真由美、鳥居本美、新川武   リガンドの換装による三部構成免疫賦活システム(TIPS)の三日熱マラリア伝搬阻止ワクチン機能への影響  

    第82回日本寄生虫学会大会  第82回日本寄生虫学会大会

     More details

    Event date: 2013.3

    Language:Japanese  

    Venue:東京  

    国内学会

  • 原國哲也、宮田健、大城聡、平良東紀、新川武   コレラトキシンB鎖の構造安定化に向けた分子改変  

    第16回日本ワクチン学会学術集会  第16回日本ワクチン学会学術集会

     More details

    Event date: 2012.11

    Language:Japanese  

    Venue:神奈川  

    国内学会

  • 宮田健、原國哲也、田福宣治、坪井敬文、Jetsumon Sattabongkot、橘真由美、鳥居本美、只野昌之、新川武   リガンド部分変更による三部構成免疫賦活システム(TIPS)の機能性向上の検討  

    第16回日本ワクチン学会学術集会  第16回日本ワクチン学会学術集会

     More details

    Event date: 2012.11

    Language:Japanese  

    Venue:神奈川  

    国内学会

  • 宮田 健   高分子量化技術を活用した効果的なサブユニットワクチンの可能性  

    第32回 日本動物細胞工学会2019年度大会  2019.7 

  • 栗原 浩一, 李 在萬, 日下部 宜宏, 南畑 孝介, 髙原 茉莉, 神谷 典穂, イブラヒム ヒッシャム, 宮田 健   酵素反応を利用した分子デザインによる機能性ワクチン抗原の作製とマラリアワクチンへの応用  

    第22回日本ワクチン学会学術集会  2018.12 

  • 宮田 健   組換えタンパク質によるサブユニットワクチン開発基盤の構築  

    第42回 蛋白質と酵素の構造と機能に関する九州シンポジウム  2018.8 

  • 増田 亮津, 宮田 健, 南畑 孝介, 神谷 典穂, 李 在萬, 日下部 宜宏   昆虫工場を利用したウイルス様粒子ワクチン生産系の確立とその応用  

    衛生動物  2019.3  日本衛生動物学会

  • 阿久津 澪, 中澤 光, 二井手 哲平, 亀田 倫史, 宮田 健, 梅津 光央   抗体の配列柔軟性を利用した部分構造移植による機能性タンパク質の創出  

    日本生物工学会大会講演要旨集  2019.8  (公社)日本生物工学会

  • 阿久津澪, 中澤光, 二井出哲平, 亀田倫史, 宮田健, 梅津光央   抗体の配列柔軟性を使用した部分構造移植による機能性タンパク質の創出  

    第71回日本生物工学大会  2019.9 

  • 宮田 健   会合体を用いた新規ワクチンプラットフォームの創製  

    第27回繊維学会西部支部セミナー  2017.2 

  • 草木迫 浩大, 正谷 達謄, 宮田 健, Galay Remil, 白藤 梨可[梅宮], 前田 大輝, Talactac Melbourne, Hernandez Emmanuel, 辻 尚利, 望月 雅美, 藤崎 幸蔵, 田仲 哲也   マダニペルオキシレドキシンの特性解明(ペルオキシレドキシンの性状解析並びに吸血・産卵に果たす役割について)  

    日本獣医学会学術集会講演要旨集  2017.8  (公社)日本獣医学会

  • 津田尚明, 中村正幸, 宮田 健, 岩井 久   ジャガイモそうか病菌に対するラクトフェリン (LF) の抗菌作用について  

    日本植物病理学大会  2018.3 

  • 宮田 健, 李 在萬, 日下部宜宏   カイコ発現マラリアワクチン抗原の機能性について  

    日本農芸化学会2018年度大会  2018.3 

  • 大林 桃百香, 相良 誠也, 五反田 麻里, 田仲 哲也, イブラヒム ヒッシャム, 筏井 宏実, 宮田 健   ウシラクトフェリン (bLF) のマラリア原虫増殖阻害機能  

    日本ラクトフェリン学会第8回学術集会  2018.10 

  • 宮田 健   ウシラクトフェリン (bLF) のマラリア原虫増殖阻害機能  

    ラクトフェリンセミナー2019  2019.5 

  • 川上了史, 那須英里圭, 宮田健, 宮本憲二   アニオン性タンパク質ナノ粒子TIP60とカチオン性タンパク質の相互解析  

    日本化学会 第99春季年会  2019.3 

▼display all

Intellectual Property

  • 経口ワクチン組成物

    大和建太, 宮田健, 日下部宜宏, 李在萬, 増田亮津

     More details

    Applicant:鹿児島大学、九州大学、KAICO株式会社

    Application no:特願2021-066427  Date applied:2021.4

  • 重合化ポリペプチドの集合体の製造方法及び重合化ポリペプチドを高分子量化させる方法

    宮田 健, 栗原 浩一, 神谷 典穂, 南畑 孝介, 日下部 宜宏

     More details

    Application no:特願2019-079549  Date applied:2019.4

  • マラリア原虫増殖阻害用組成物

    宮田 健, 田仲哲也, 大林桃百香

     More details

    Application no:特願2018-197158  Date applied:2018.10

  • 豚の浮腫病を予防するワクチン

    横川 顕治, 脇 貴志, 本田 容子, 上藤 洋敬, 瀬脇 智満, 新川 武, 原國 哲也, 宮田 健

     More details

    Applicant:一般財団法人化学及血清療法研究所, 株式会社ジェクタス・イノベーターズ

    Application no:特願2014-543268  Date applied:2013.10

    Patent/Registration no:特許第6172582号  Date issued:2017.7

    J-GLOBAL

Awards

  • 日本農芸化学会 西日本・中四国・関西支部優秀発表賞

    2021.9   日本農芸化学会   天然資源由来新規アジュバント機能成分の探索および組換えタンパク質による新規アジュバント分子の開発

    里圭太,北川大樹,池田勇太,イブラヒムヒッシャム,宮田健

     More details

    Award type:Award from Japanese society, conference, symposium, etc.  Country:Japan

  • 日本ラクトフェリン学会賞 冨田賞

    2018.10   日本ラクトフェリン学会   ウシラクトフェリン (bLF) のマラリア原虫増殖阻害機能

    大林桃百香、筏井宏美、宮田健

     More details

    Award type:International academic award (Japan or overseas)  Country:Japan

Research Projects

  • Developing a Novel Eating Vaccine with Silkworms

    Grant number:22H02501  2022.4 - 2027.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

      More details

    Grant amount:\17160000 ( Direct Cost: \13200000 、 Indirect Cost:\3960000 )

  • Development of Functional Protein Nanobuilding Block Complexes and their Applications

    Grant number:19H02522  2019.4 - 2022.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

      More details

    Grant amount:\17420000 ( Direct Cost: \13400000 、 Indirect Cost:\4020000 )

  • Development of advanced pseud-parasite with self-assembly-nanoparts (SNAP) for subunit vaccines

    Grant number:17K08810  2017.4 - 2020.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    Miyata Takeshi

      More details

    Grant amount:\4810000 ( Direct Cost: \3700000 、 Indirect Cost:\1110000 )

    We have been developing subunit vaccines based on recombinant protein antigens using several self-nanoassembley-parts(SNAPs). In detail, a mesh-like molecule produced by modifying a branched-chain to the antigen showed a remarkable enhancement of the antibody production response in animal experiments. To put this technology to practical use, we are working on the optimization of the method of production.

  • Creation of vaccines and RNA acaricides targeting tick antioxidative molecules for controlling ticks

    Grant number:16H05028  2016.4 - 2019.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

    TANAKA TETSUYA

      More details

    Grant amount:\17550000 ( Direct Cost: \13500000 、 Indirect Cost:\4050000 )

    The purpose of this study was to clarify the characteristics of the redox balance control mechanism of ticks, to provide new knowledge to the development, research of tick suppression, and to create anti-tick vaccines and RNA acaricides targeting them. Therefore, we worked on the theme of antioxidant molecules, and identified and characterized peroxiredoxin (Prx), glutathione S-transferase (GST), and ferritin (Fer). We investigated the role of antioxidant molecules against acaricides and embryonic development of ticks. Thus, exploiting the properties of antioxidant molecules has been demonstrated to be a promising target molecule for combating ticks.

  • A New nanoparticle glycogen for development of vaccine against malaria

    Grant number:26460511  2014.4 - 2017.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    Miyata Takeshi

      More details

    Grant amount:\4940000 ( Direct Cost: \3800000 、 Indirect Cost:\1140000 )

    We have developed a new technology to enhance immune responses by generating complex which composed DNA-binding protein fused vaccine antigen, DNA and nano-particle glycogen (NPG). In this system, NPG was used as scaffold material, DNA was used as crosslinker material for vaccine antigen and NPG. New tricomponent vaccine complex (DBP-Vaccine/DNA/NPG) function was evaluated using an ookinete surface protein of Plasmodium vivax, Pvs25. The tricomplex immunized mice were conferred a high immune response compared to Pvs25 alone or DBP-Pvs25/DNA complex immunized groups. This system may be a promising approach for development of subunit vaccines against malaria.

 

Teaching Experience

  • 情報活用

    2018.4
    Institution:鹿児島大学

     More details

    Level:Undergraduate (liberal arts)  Country:Japan

  • 動物性食品学

    2017.4
    Institution:鹿児島大学

 

Media Coverage

  • カイコから経口ワクチン製造を目指す鹿児島大准教授宮田健さん Newspaper, magazine

    南日本新聞  かお  2021.7

  • カイコから経口ワクチン Newspaper, magazine

    南日本新聞  1  2021.6

  • カイコのサナギから製造 Newspaper, magazine

    毎日新聞 福岡版  19面 地域  2021.6

     More details

    Author:Other